Manufacturer Communications With Payers Easier Under US FDA Guidance, But Challenges Remain
Executive Summary
Process for sharing health care economic and other information has been simplified for manufacturers, and payers are seeing more economic modeling data earlier as a result. However, there is still uncertainty as to the scope of who may communicate the information, and to whom, under the agency’s 2018 final guidance, experts said.